Detalhe da pesquisa
1.
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease.
Ann Hepatol;
29(5): 101512, 2024 May 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38710473
2.
Metabolic dysfunction-associated fatty liver disease: a year in review.
Curr Opin Gastroenterol;
38(3): 251-260, 2022 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35143431
3.
Therapeutic plasma-exchange improves systemic inflammation and survival in acute-on-chronic liver failure: A propensity-score matched study from AARC.
Liver Int;
41(5): 1083-1096, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33529450
4.
Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure.
Liver Int;
41(1): 150-157, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32970356
5.
Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.
Am J Gastroenterol;
114(6): 929-937, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31021832
6.
AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study.
Hepatol Int;
17(3): 662-675, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36571711
7.
MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective.
Aliment Pharmacol Ther;
53(10): 1080-1089, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33751604
8.
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
Hepatol Int;
15(5): 1031-1048, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34427860
9.
Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF.
Hepatol Int;
15(3): 753-765, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34173167
10.
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.
Hepatol Int;
13(6): 695-705, 2019 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31650510
11.
Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
Hepatol Int;
16(2): 486-487, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35076895
12.
Hepatitis C virus as a systemic disease: reaching beyond the liver.
Hepatol Int;
10(3): 415-23, 2016 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26660706